Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.250
+0.030 (1.35%)
At close: Apr 28, 2026, 4:00 PM EDT
2.230
-0.020 (-0.89%)
After-hours: Apr 28, 2026, 7:33 PM EDT
Neumora Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -236.93 | -243.79 | -235.93 | -130.9 | -237.31 | |
| Depreciation & Amortization | 0.21 | 0.63 | 0.67 | 0.59 | 0.54 | |
| Other Amortization | 1.21 | - | - | - | - | |
| Loss (Gain) From Sale of Assets | 0.64 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 63.9 | 13 | 157 | |
| Loss (Gain) From Sale of Investments | -2.93 | -5.72 | -3.74 | -0.71 | - | |
| Stock-Based Compensation | 29.88 | 39.99 | 17.24 | 8.3 | 4.27 | |
| Other Operating Activities | 1.92 | 3.31 | 3.48 | 1.77 | 1.04 | |
| Change in Accounts Payable | 0.07 | 2.87 | -0.58 | -1.25 | -0.76 | |
| Change in Other Net Operating Assets | -0.51 | 19.76 | -8.32 | -5.7 | -0.2 | |
| Operating Cash Flow | -206.44 | -182.94 | -163.28 | -114.9 | -75.42 | |
| Capital Expenditures | - | -0.78 | -4.71 | -13.51 | -0.82 | |
| Sale of Property, Plant & Equipment | 0.22 | - | - | - | - | |
| Investment in Securities | 168.3 | -69.78 | 69.09 | -154.5 | - | |
| Investing Cash Flow | 168.52 | -70.56 | 64.39 | -168.01 | -0.82 | |
| Long-Term Debt Issued | 57.16 | - | - | - | - | |
| Net Debt Issued (Repaid) | 57.16 | - | - | - | - | |
| Issuance of Common Stock | 19.93 | 21.6 | 236.23 | 2.66 | 3.47 | |
| Repurchase of Common Stock | - | - | -0.49 | - | - | |
| Other Financing Activities | - | - | -3.8 | -0.92 | -1.21 | |
| Financing Cash Flow | 77.09 | 21.6 | 231.94 | 115.74 | 293.51 | |
| Net Cash Flow | 39.17 | -231.89 | 133.05 | -167.17 | 217.27 | |
| Free Cash Flow | -206.44 | -183.71 | -167.99 | -128.41 | -76.24 | |
| Free Cash Flow Per Share | -1.26 | -1.15 | -2.58 | -4.72 | -3.48 | |
| Cash Interest Paid | 1.5 | - | - | - | - | |
| Cash Income Tax Paid | 0.32 | 0.47 | - | - | - | |
| Levered Free Cash Flow | -115.71 | -100.7 | -111.24 | -93.02 | -37.08 | |
| Unlevered Free Cash Flow | -114.91 | -100.7 | -111.24 | -93.02 | -37.08 | |
| Change in Working Capital | -0.44 | 22.64 | -8.9 | -6.95 | -0.96 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.